Abstract: The invention features methods and compositions feature lapatinib and/or rapamycin for treating or preventing a cardiac condition induced by anthracycline treatment.
Type:
Grant
Filed:
August 20, 2013
Date of Patent:
September 1, 2015
Assignee:
Genesys Research Institute, Inc.
Inventors:
Xinhua Yan, James P. Morgan, Lewis C. Cantley